INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Venomics AI
Back to Newsroom
🏢Organization Dossier

Venomics AI

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

2 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Startups & Venture Capital 08 Nov 2026, 02:00 PM IST

Venomics AI Raises $2.7 Million to Turn Venom Into Medicine

Bengaluru-based biotechnology startup Venomics AI has raised $2.7 million, or about ₹25.5 crore, in a pre-seed round co-led by Speciale Invest and other backers, as it seeks to build a platform that uses venom-derived molecules for drug discovery. The company is positioning itself at the intersection of biotechnology and artificial intelligence, targeting a field with significant therapeutic promise but long development cycles and high scientific risk.

By RDU Global Wire5 min read
Startups & Venture Capital07 Nov 2026, 08:00 PM IST

Venomics AI Raises $2.7 Million to Turn Venom Into Medicine

Bengaluru-based biotechnology startup Venomics AI has raised $2.7 million, or about ₹25.5 crore, in a pre-seed round co-led by Speciale Invest and other backers, as it seeks to use artificial intelligence to accelerate drug discovery from animal venoms. The company is targeting a long-standing scientific challenge: converting highly complex natural toxins into precise therapeutic candidates for diseases with limited treatment options.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Venomics AI: